A detailed history of Allen Mooney & Barnes Investment Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Allen Mooney & Barnes Investment Advisors LLC holds 84,604 shares of ABBV stock, worth $15.3 Million. This represents 2.84% of its overall portfolio holdings.

Number of Shares
84,604
Previous 87,131 2.9%
Holding current value
$15.3 Million
Previous $14.9 Billion 11.8%
% of portfolio
2.84%
Previous 2.67%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $414,023 - $503,706
-2,527 Reduced 2.9%
84,604 $16.7 Billion
Q2 2024

Jul 11, 2024

BUY
$154.79 - $180.76 $56,343 - $65,796
364 Added 0.42%
87,131 $14.9 Billion
Q1 2024

Apr 12, 2024

SELL
$159.82 - $182.1 $188,747 - $215,060
-1,181 Reduced 1.34%
86,767 $14.5 Billion
Q4 2023

Jan 22, 2024

BUY
$137.6 - $154.97 $175,440 - $197,586
1,275 Added 1.47%
87,948 $13.6 Billion
Q3 2023

Nov 21, 2023

BUY
$133.59 - $154.65 $11.6 Million - $13.4 Million
86,673 New
86,673 $12.9 Billion
Q2 2023

May 23, 2024

BUY
$132.51 - $164.9 $148,543 - $184,852
1,121 Added 1.36%
83,431 $11.2 Billion
Q1 2023

May 23, 2024

BUY
$144.61 - $166.54 $142,007 - $163,542
982 Added 1.21%
82,310 $13.1 Billion
Q4 2022

May 23, 2024

SELL
$138.31 - $165.87 $752,268 - $902,166
-5,439 Reduced 6.27%
81,328 $13.1 Billion
Q3 2022

May 23, 2024

BUY
$134.21 - $153.93 $345,188 - $395,907
2,572 Added 3.28%
81,013 $10.9 Billion
Q2 2022

May 23, 2024

BUY
$137.62 - $174.96 $115,187 - $146,441
837 Added 1.08%
78,441 $12 Billion
Q1 2022

May 23, 2024

SELL
$131.98 - $163.75 $1.21 Million - $1.5 Million
-9,163 Reduced 10.56%
77,604 $12.6 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Allen Mooney & Barnes Investment Advisors LLC Portfolio

Follow Allen Mooney & Barnes Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allen Mooney & Barnes Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allen Mooney & Barnes Investment Advisors LLC with notifications on news.